Forge Global Holdings, Inc.

NYSE:FRGE Stock Report

Market Cap: US$205.2m

Forge Global Holdings Valuation

Is FRGE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FRGE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate FRGE's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate FRGE's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for FRGE?

Key metric: As FRGE is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for FRGE. This is calculated by dividing FRGE's market cap by their current revenue.
What is FRGE's PS Ratio?
PS Ratio2.6x
SalesUS$79.80m
Market CapUS$205.19m

Price to Sales Ratio vs Peers

How does FRGE's PS Ratio compare to its peers?

The above table shows the PS ratio for FRGE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
COHN Cohen
0.2xn/aUS$57.6m
MKTW MarketWise
0.06x-3.5%US$172.0m
RILY B. Riley Financial
0.1xn/aUS$153.0m
SAMG Silvercrest Asset Management Group
1.4x6.8%US$255.5m
FRGE Forge Global Holdings
2.6x21.9%US$205.2m

Price-To-Sales vs Peers: FRGE is expensive based on its Price-To-Sales Ratio (2.6x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does FRGE's PS Ratio compare vs other companies in the US Capital Markets Industry?

23 CompaniesPrice / SalesEstimated GrowthMarket Cap
SNEX StoneX Group
0.03xn/aUS$3.27b
OPY Oppenheimer Holdings
0.5xn/aUS$629.80m
BKKT Bakkt Holdings
0.1x-151.2%US$396.17m
MKTW MarketWise
0.06x-3.5%US$172.02m
FRGE 2.6xIndustry Avg. 3.3xNo. of Companies23PS03.26.49.612.816+
23 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: FRGE is good value based on its Price-To-Sales Ratio (2.6x) compared to the US Capital Markets industry average (3.3x).


Price to Sales Ratio vs Fair Ratio

What is FRGE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FRGE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.6x
Fair PS Ratio2.1x

Price-To-Sales vs Fair Ratio: FRGE is expensive based on its Price-To-Sales Ratio (2.6x) compared to the estimated Fair Price-To-Sales Ratio (2.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst FRGE forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1.11
US$3.68
+231.1%
53.2%US$7.00US$2.00n/a4
Nov ’25US$1.13
US$3.88
+242.9%
48.6%US$7.00US$2.00n/a4
Oct ’25US$1.25
US$3.88
+210.0%
48.6%US$7.00US$2.00n/a4
Sep ’25US$1.40
US$3.88
+176.8%
48.6%US$7.00US$2.00n/a4
Aug ’25US$1.37
US$3.88
+182.8%
48.6%US$7.00US$2.00n/a4
Jul ’25US$1.44
US$3.88
+169.1%
48.6%US$7.00US$2.00n/a4
Jun ’25US$1.58
US$3.88
+145.3%
48.6%US$7.00US$2.00n/a4
May ’25US$1.91
US$3.88
+102.9%
48.6%US$7.00US$2.00n/a4
Apr ’25US$1.82
US$3.88
+112.9%
48.6%US$7.00US$2.00n/a4
Mar ’25US$1.95
US$4.00
+105.1%
44.2%US$7.00US$2.50n/a4
Feb ’25US$1.92
US$4.00
+108.3%
44.2%US$7.00US$2.50n/a4
Jan ’25US$3.43
US$4.00
+16.6%
44.2%US$7.00US$2.50n/a4
Dec ’24US$3.32
US$4.00
+20.5%
44.2%US$7.00US$2.50n/a4
Nov ’24US$2.50
US$3.00
+20.0%
13.6%US$3.50US$2.50US$1.133
Oct ’24US$2.03
US$4.00
+97.0%
44.2%US$7.00US$2.50US$1.254
Sep ’24US$2.35
US$4.00
+70.2%
44.2%US$7.00US$2.50US$1.404
Aug ’24US$2.89
US$3.23
+11.6%
68.1%US$7.00US$1.75US$1.374
Jul ’24US$2.43
US$3.23
+32.7%
68.1%US$7.00US$1.75US$1.444
Jun ’24US$1.57
US$3.23
+105.4%
68.1%US$7.00US$1.75US$1.584
May ’24US$1.25
US$3.23
+158.0%
68.1%US$7.00US$1.75US$1.914
Apr ’24US$1.75
US$3.48
+98.6%
75.6%US$8.00US$1.75US$1.824
Mar ’24US$1.79
US$3.48
+94.1%
75.6%US$8.00US$1.75US$1.954
Feb ’24US$2.15
US$3.38
+57.0%
79.2%US$8.00US$1.75US$1.924
Jan ’24US$1.73
US$3.88
+124.0%
91.3%US$10.00US$1.75US$3.434
Dec ’23US$1.37
US$4.50
+228.5%
86.4%US$10.00US$1.75US$3.323

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies